---
title: "Provision of Stereotactic Radiosurgery / Radiotherapy (SRS /SRT) Services - (Intracranial) All Ages, All Indications including Paediatric Neuro-Oncology SRS/SRT Services"
ocid: "ocds-h6vhtk-042ce3"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-042ce3"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-042ce3.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-042ce3.json"
source: "Find A Tender Service"
current_stage: "Tender"
buyer: "NHS ENGLAND"
published: "2024-01-12"
---

# Provision of Stereotactic Radiosurgery / Radiotherapy (SRS /SRT) Services - (Intracranial) All Ages, All Indications including Paediatric Neuro-Oncology SRS/SRT Services

Buyer: NHS ENGLAND  
Current stage: Tender  
OCID: ocds-h6vhtk-042ce3

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-042ce3)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-042ce3.json)

## Summary

The NHS Arden and Greater East Midlands Commissioning Support Unit, acting on behalf of NHS England, is conducting a procurement process for the provision of Stereotactic Radiosurgery / Radiotherapy (SRS /SRT) Services across England. The procurement covers all tiers of service for Intracranial conditions, including paediatric oncology, with a total contract value of £83,500,000. The process includes four separate lots covering different regions of England and has key submission deadlines, including a closing date for completed responses of 12:00pm on Friday 23rd February 2024.

This tender presents significant opportunities for healthcare service providers specializing in radiotherapy and neurosurgical treatments. Businesses offering integrated neurosurgical and oncology services, especially those capable of delivering Tier 1 & 2 services to generate 100 cases per year, are well-suited to compete. The duration of the contract is 5 years with a possible extension, providing stable revenue streams for successful bidders. Interested providers must adhere to strict quality assurance requirements and respond to the procurement documentation available online.

## Notice

NHS Arden and Greater East Midlands Commissioning Support unit on behalf of NHS
England wish to procure under Lots four All Tiers Stereotactic Radiosurgery / Radiotherapy
(SRS /SRT) Services - (Intracranial) all ages, including paediatric oncology services covering
England.
SRS/SRT are methods of delivering doses of precisely targeted intracranial radiotherapy
treatment and used for a wide range of malignant and benign intracranial conditions, as setout
within NHS England clinical commissioning policy. This comprises Tier 1-2 indications of
cerebral metastases, non-skull base meningiomas, skull base tumours including Vestibular
Schwannoma and meningioma, pituitary adenoma, and the Tier 3-4 indications including
arteriovenous malformations, trigeminal neuralgia and paediatric CNS tumours. The
prevalence of these conditions varies from less than one per 100,000 population to up to 30
per 100,000.
The two Service Specification include a tiered service model, based on clinical indication
prevalence and complexity and groups together more common, less complex conditions
(called Tier 1&2) and less common and more complex conditions (called Tier 3&4).
The two service specification, cover:
(i) Tier 1 & 2 indications for adults; and
(ii) All tiers, all ages and all conditions as this better reflects service provision and pathways.
This procurement is focused on the ALL Tiers, all ages Service Specification ONLY.
The Lots will cover the whole of England based on the following Geographies:
1. Lot 1: North England and North West England
2. Lot 2: South Yorkshire and Midlands
3. Lot 3: Greater London, East of England and South England
4. Lot 4: South West of England

### Lot Information

Lot 1 North England and North West England

The objective of this procurement is to commission four Lots All Tiers Stereotactic Radiosurgery / Radiotherapy (SRS /SRT) Services - (Intracranial) all ages, including paediatric oncology services covering England. The eligibility criteria, lotting structure and scope of services are detailed in this document. Bidders must be located within the Lot geography for which they are bidding. Bidders are only required to deliver the Tier 1 and 2 services within the geographical catchment area served by the neurosurgical service in which they are based and not for the whole Lot geography.
On completion of the procurement process, NHS England will complete a Market Engagement exercise scheduled, to follow the outcome from this procurement process for the remaining Tier 1 & Tier 2 services which will be open to all bidders.
In order to be eligible, bidders must ensure that:
a) The Service is delivered as part of an integrated neurosurgical and oncology service located within the same geographical area or city serving a population of at least 2 million in order to generate 100 SRS/SRT Tier 1&2 cases per year.
b) The Service is delivered as part of an integrated paediatric neurosurgical and oncology service, commissioned to provide Paediatric Photon Radiotherapy located within the same geographical area or city to a Children's Cancer Principal Treatment Centre (PTC)
c) The neurosurgical centre must host the full range of specialist intracranial Multi-disciplinary Teams (MDT) for all clinical indications for adult and paediatric intracranial tumours, namely, combined Neurosciences Brain and Central Nervous System (CNS) MDT, and / or the individual neuro-oncology MDTs, skull base MDT, and pituitary MDT, neuro-vascular MDT and Paediatric oncology MDTs as listed in Table 1.2.
d) The Service must deliver the complete range of SRS/SRT treatments including paediatric oncology indications (Table 1.2) and participate in the full range of specialist neurosurgical MDTs and generate a minimum annual activity volume of: (i) 100 SRS/SRT Tier 1 and Tier 2 cases; plus (ii) circa 200 Tier 3 and Tier 4 (combined) cases.
SRS/SRT are methods of delivering doses of precisely targeted intracranial radiotherapy treatment and used for a wide range of malignant and benign intracranial conditions, as set-out within NHS England clinical commissioning policy. This comprises Tier 1-2 indications of cerebral metastases, non-skull base meningiomas, skull base tumours including Vestibular Schwannoma and meningioma, pituitary adenoma, and the Tier 3-4 indications including arteriovenous malformations, trigeminal neuralgia and paediatric CNS tumours. The prevalence of these conditions varies from less than one per 100,000 population to up to 30 per 100,000. 
This tiered service model is based on clinical indication prevalence and complexity and groups together more common, less complex conditions (called Tier 1&2) and less common and more complex conditions (called Tier 3&4).
The two service specifications, cover: 
(i) Tier 1 & 2 indications for adults; and 
(ii) All tiers, all ages and all conditions as this better reflects service provision and pathways.
This procurement is focused on the ALL Tiers, all ages Service Specification ONLY.
The Lots will cover the whole of England based on the following Geographies:
1. Lot 1: North England and North West England
2. Lot 2: South Yorkshire and Midlands
3. Lot 3: Greater London, East of England and South England
4. Lot 4: South West of England. Additional information: Bidders will be required to adhere to the recommendations detailed in the NPSA report 'Towards Safety in Radiotherapy' and will be required to meet the Pre-Assessment Radiotherapy Quality Assurance Requirements by June 2024 at the latest.
Bidders will be required to complete external Radiotherapy Quality Assurance (RTTQA) prior to contract award.
On completion of the procurement process, NHS England will complete a Market Engagement exercise scheduled, to follow the outcome from this procurement process for the remaining Tier 1 & Tier 2 services which will be open to all bidders.
The duration of this contract will be for a period of 5 years with the Commissioner having the option to extend the Contract for up to a further two years. Providers wishing to be considered for the delivery of these services will need to respond to the provider selection documentation and submit responses prior to the deadline stated in this notice. The ITT documentation including a questionnaire is available through the Atamis (Health Family) portal:
https://health-family.force.com/s/Welcome
(https://health-family.force.com/s/Welcome)
The reference is C220364 and the closing date for completed ITT responses is 12:00pm, midday on Friday 23rd February 2024. There will also be an opportunity to attend a market engagement event via Microsoft Teams at 13:00pm on Thursday 25th January 2024. If you would like to participate in this event, please email:
josselin.canevet@nhs.net
by Wednesday 24th January 2024. All slides and questions and responses will be made available to all bidders following the event.

Lot 2 South Yorkshire and Midlands

The objective of this procurement is to commission four Lots All Tiers Stereotactic Radiosurgery / Radiotherapy (SRS /SRT) Services - (Intracranial) all ages, including paediatric oncology services covering England. The eligibility criteria, lotting structure and scope of services are detailed in this document. Bidders must be located within the Lot geography for which they are bidding. Bidders are only required to deliver the Tier 1 and 2 services within the geographical catchment area served by the neurosurgical service in which they are based and not for the whole Lot geography.
On completion of the procurement process, NHS England will complete a Market Engagement exercise scheduled, to follow the outcome from this procurement process for the remaining Tier 1 & Tier 2 services which will be open to all bidders.
In order to be eligible, bidders must ensure that:
a) The Service is delivered as part of an integrated neurosurgical and oncology service located within the same geographical area or city serving a population of at least 2 million in order to generate 100 SRS/SRT Tier 1&2 cases per year.
b) The Service is delivered as part of an integrated paediatric neurosurgical and oncology service, commissioned to provide Paediatric Photon Radiotherapy located within the same geographical area or city to a Children's Cancer Principal Treatment Centre (PTC)
c) The neurosurgical centre must host the full range of specialist intracranial Multi-disciplinary Teams (MDT) for all clinical indications for adult and paediatric intracranial tumours, namely, combined Neurosciences Brain and Central Nervous System (CNS) MDT, and / or the individual neuro-oncology MDTs, skull base MDT, and pituitary MDT, neuro-vascular MDT and Paediatric oncology MDTs as listed in Table 1.2.
d) The Service must deliver the complete range of SRS/SRT treatments including paediatric oncology indications (Table 1.2) and participate in the full range of specialist neurosurgical MDTs and generate a minimum annual activity volume of: (i) 100 SRS/SRT Tier 1 and Tier 2 cases; plus (ii) circa 200 Tier 3 and Tier 4 (combined) cases.
SRS/SRT are methods of delivering doses of precisely targeted intracranial radiotherapy treatment and used for a wide range of malignant and benign intracranial conditions, as set-out within NHS England clinical commissioning policy. This comprises Tier 1-2 indications of cerebral metastases, non-skull base meningiomas, skull base tumours including Vestibular Schwannoma and meningioma, pituitary adenoma, and the Tier 3-4 indications including arteriovenous malformations, trigeminal neuralgia and paediatric CNS tumours. The prevalence of these conditions varies from less than one per 100,000 population to up to 30 per 100,000. 
This tiered service model is based on clinical indication prevalence and complexity and groups together more common, less complex conditions (called Tier 1&2) and less common and more complex conditions (called Tier 3&4).
The two service specifications, cover: 
(i) Tier 1 & 2 indications for adults; and 
(ii) All tiers, all ages and all conditions as this better reflects service provision and pathways.
This procurement is focused on the ALL Tiers, all ages Service Specification ONLY.
The Lots will cover the whole of England based on the following Geographies:
1. Lot 1: North England and North West England
2. Lot 2: South Yorkshire and Midlands
3. Lot 3: Greater London, East of England and South England
4. Lot 4: South West of England. Additional information: Bidders will be required to adhere to the recommendations detailed in the NPSA report 'Towards Safety in Radiotherapy' and will be required to meet the Pre-Assessment Radiotherapy Quality Assurance Requirements by June 2024 at the latest.
Bidders will be required to complete external Radiotherapy Quality Assurance (RTTQA) prior to contract award.
On completion of the procurement process, NHS England will complete a Market Engagement exercise scheduled, to follow the outcome from this procurement process for the remaining Tier 1 & Tier 2 services which will be open to all bidders.
The duration of this contract will be for a period of 5 years with the Commissioner having the option to extend the Contract for up to a further two years. Providers wishing to be considered for the delivery of these services will need to respond to the provider selection documentation and submit responses prior to the deadline stated in this notice. The ITT documentation including a questionnaire is available through the Atamis (Health Family) portal:
https://health-family.force.com/s/Welcome
(https://health-family.force.com/s/Welcome)
The reference is C220364 and the closing date for completed ITT responses is 12:00pm, midday on Friday 23rd February 2024. There will also be an opportunity to attend a market engagement event via Microsoft Teams at 13:00pm on Thursday25th January 2024. If you would like to participate in this event, please email:
josselin.canevet@nhs.net
by Wednesday 24th January 2024. All slides and questions and responses will be made available to all bidders following the event.

Lot 3 Greater London, East of England and South England

The objective of this procurement is to commission four Lots All Tiers Stereotactic Radiosurgery / Radiotherapy (SRS /SRT) Services - (Intracranial) all ages, including paediatric oncology services covering England. The eligibility criteria, lotting structure and scope of services are detailed in this document. Bidders must be located within the Lot geography for which they are bidding. Bidders are only required to deliver the Tier 1 and 2 services within the geographical catchment area served by the neurosurgical service in which they are based and not for the whole Lot geography.
On completion of the procurement process, NHS England will complete a Market Engagement exercise scheduled, to follow the outcome from this procurement process for the remaining Tier 1 & Tier 2 services which will be open to all bidders.
In order to be eligible, bidders must ensure that:
a) The Service is delivered as part of an integrated neurosurgical and oncology service located within the same geographical area or city serving a population of at least 2 million in order to generate 100 SRS/SRT Tier 1&2 cases per year.
b) The Service is delivered as part of an integrated paediatric neurosurgical and oncology service, commissioned to provide Paediatric Photon Radiotherapy located within the same geographical area or city to a Children's Cancer Principal Treatment Centre (PTC)
c) The neurosurgical centre must host the full range of specialist intracranial Multi-disciplinary Teams (MDT) for all clinical indications for adult and paediatric intracranial tumours, namely, combined Neurosciences Brain and Central Nervous System (CNS) MDT, and / or the individual neuro-oncology MDTs, skull base MDT, and pituitary MDT, neuro-vascular MDT and Paediatric oncology MDTs as listed in Table 1.2.
d) The Service must deliver the complete range of SRS/SRT treatments including paediatric oncology indications (Table 1.2) and participate in the full range of specialist neurosurgical MDTs and generate a minimum annual activity volume of: (i) 100 SRS/SRT Tier 1 and Tier 2 cases; plus (ii) circa 200 Tier 3 and Tier 4 (combined) cases.
SRS/SRT are methods of delivering doses of precisely targeted intracranial radiotherapy treatment and used for a wide range of malignant and benign intracranial conditions, as set-out within NHS England clinical commissioning policy. This comprises Tier 1-2 indications of cerebral metastases, non-skull base meningiomas, skull base tumours including Vestibular Schwannoma and meningioma, pituitary adenoma, and the Tier 3-4 indications including arteriovenous malformations, trigeminal neuralgia and paediatric CNS tumours. The prevalence of these conditions varies from less than one per 100,000 population to up to 30 per 100,000. 
This tiered service model is based on clinical indication prevalence and complexity and groups together more common, less complex conditions (called Tier 1&2) and less common and more complex conditions (called Tier 3&4).
The two service specifications, cover: 
(i) Tier 1 & 2 indications for adults; and 
(ii) All tiers, all ages and all conditions as this better reflects service provision and pathways.
This procurement is focused on the ALL Tiers, all ages Service Specification ONLY.
The Lots will cover the whole of England based on the following Geographies:
1. Lot 1: North England and North West England
2. Lot 2: South Yorkshire and Midlands
3. Lot 3: Greater London, East of England and South England
4. Lot 4: South West of England. Additional information: Bidders will be required to adhere to the recommendations detailed in the NPSA report 'Towards Safety in Radiotherapy' and will be required to meet the Pre-Assessment Radiotherapy Quality Assurance Requirements by June 2024 at the latest.
Bidders will be required to complete external Radiotherapy Quality Assurance (RTTQA) prior to contract award.
On completion of the procurement process, NHS England will complete a Market Engagement exercise scheduled, to follow the outcome from this procurement process for the remaining Tier 1 & Tier 2 services which will be open to all bidders.
The duration of this contract will be for a period of 5 years with the Commissioner having the option to extend the Contract for up to a further two years. Providers wishing to be considered for the delivery of these services will need to respond to the provider selection documentation and submit responses prior to the deadline stated in this notice. The ITT documentation including a questionnaire is available through the Atamis (Health Family) portal:
https://health-family.force.com/s/Welcome
(https://health-family.force.com/s/Welcome)
The reference is C220364 and the closing date for completed ITT responses is 12:00pm, midday on Friday 23rd February 2024. There will also be an opportunity to attend a market engagement event via Microsoft Teams at 13:00pm on Thursday 25th January 2024. If you would like to participate in this event, please email:
josselin.canevet@nhs.net
by Wednesday 24th January 2024. All slides and questions and responses will be made available to all bidders following the event.

Lot 4 South West of England

The objective of this procurement is to commission four Lots All Tiers Stereotactic Radiosurgery / Radiotherapy (SRS /SRT) Services - (Intracranial) all ages, including paediatric oncology services covering England. The eligibility criteria, lotting structure and scope of services are detailed in this document. Bidders must be located within the Lot geography for which they are bidding. Bidders are only required to deliver the Tier 1 and 2 services within the geographical catchment area served by the neurosurgical service in which they are based and not for the whole Lot geography.
On completion of the procurement process, NHS England will complete a Market Engagement exercise scheduled, to follow the outcome from this procurement process for the remaining Tier 1 & Tier 2 services which will be open to all bidders.
In order to be eligible, bidders must ensure that:
a) The Service is delivered as part of an integrated neurosurgical and oncology service located within the same geographical area or city serving a population of at least 2 million in order to generate 100 SRS/SRT Tier 1&2 cases per year.
b) The Service is delivered as part of an integrated paediatric neurosurgical and oncology service, commissioned to provide Paediatric Photon Radiotherapy located within the same geographical area or city to a Children's Cancer Principal Treatment Centre (PTC)
c) The neurosurgical centre must host the full range of specialist intracranial Multi-disciplinary Teams (MDT) for all clinical indications for adult and paediatric intracranial tumours, namely, combined Neurosciences Brain and Central Nervous System (CNS) MDT, and / or the individual neuro-oncology MDTs, skull base MDT, and pituitary MDT, neuro-vascular MDT and Paediatric oncology MDTs as listed in Table 1.2.
d) The Service must deliver the complete range of SRS/SRT treatments including paediatric oncology indications (Table 1.2) and participate in the full range of specialist neurosurgical MDTs and generate a minimum annual activity volume of: (i) 100 SRS/SRT Tier 1 and Tier 2 cases; plus (ii) circa 200 Tier 3 and Tier 4 (combined) cases.
SRS/SRT are methods of delivering doses of precisely targeted intracranial radiotherapy treatment and used for a wide range of malignant and benign intracranial conditions, as set-out within NHS England clinical commissioning policy. This comprises Tier 1-2 indications of cerebral metastases, non-skull base meningiomas, skull base tumours including Vestibular Schwannoma and meningioma, pituitary adenoma, and the Tier 3-4 indications including arteriovenous malformations, trigeminal neuralgia and paediatric CNS tumours. The prevalence of these conditions varies from less than one per 100,000 population to up to 30 per 100,000. 
This tiered service model is based on clinical indication prevalence and complexity and groups together more common, less complex conditions (called Tier 1&2) and less common and more complex conditions (called Tier 3&4).
The two service specifications, cover: 
(i) Tier 1 & 2 indications for adults; and 
(ii) All tiers, all ages and all conditions as this better reflects service provision and pathways.
This procurement is focused on the ALL Tiers, all ages Service Specification ONLY.
The Lots will cover the whole of England based on the following Geographies:
1. Lot 1: North England and North West England
2. Lot 2: South Yorkshire and Midlands
3. Lot 3: Greater London, East of England and South England
4. Lot 4: South West of England. Additional information: Bidders will be required to adhere to the recommendations detailed in the NPSA report 'Towards Safety in Radiotherapy' and will be required to meet the Pre-Assessment Radiotherapy Quality Assurance Requirements by June 2024 at the latest.
Bidders will be required to complete external Radiotherapy Quality Assurance (RTTQA) prior to contract award.
On completion of the procurement process, NHS England will complete a Market Engagement exercise scheduled, to follow the outcome from this procurement process for the remaining Tier 1 & Tier 2 services which will be open to all bidders.
The duration of this contract will be for a period of 5 years with the Commissioner having the option to extend the Contract for up to a further two years. Providers wishing to be considered for the delivery of these services will need to respond to the provider selection documentation and submit responses prior to the deadline stated in this notice. The ITT documentation including a questionnaire is available through the Atamis (Health Family) portal:
https://health-family.force.com/s/Welcome
(https://health-family.force.com/s/Welcome)
The reference is C220364 and the closing date for completed ITT responses is 12:00pm, midday on Friday 9th 23rd February 2024. There will also be an opportunity to attend a market engagement event via Microsoft Teams at 13:00pm on Thursday 25th January 2024. If you would like to participate in this event, please email:
josselin.canevet@nhs.net
by Wednesday 24th January 2024. All slides and questions and responses will be made available to all bidders following the event.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/001167-2024 |
| Notice type | Tender Notice |
| Procurement type | Standard |
| Procurement category | Services |
| Procurement method | Open |
| Procurement method details | Open procedure |
| Tender suitability | Not specified |
| Awardee scale | Not specified |
| All stages | Tender |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 12 Jan 2024 |
| Submission deadline | 23 Feb 2024 |
| Future notice date | Not specified |
| Award date | Not specified |
| Contract period | 30 Sep 2024 - 30 Sep 2031 |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £83,500,000 |
| Lots value | £83,525,900 |
| Awards value | Not specified |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Active |
| Lots status | Active |
| Awards status | Not specified |
| Contracts status | Not specified |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | NHS ENGLAND |
| Locality | LEEDS |
| Post town | Leeds |
| Postcode | LS2 7UE |
| Country | England |
| ITL 1 | TLE Yorkshire and The Humber |
| ITL 2 | TLE4 West Yorkshire |
| ITL 3 | TLE42 Leeds |
| Local authority | Leeds |
| Electoral ward | Little London & Woodhouse |
| Westminster constituency | Leeds Central and Headingley |
| Delivery location | Not specified |

## CPV Codes

### Divisions

- 85 - Health and social work services

### Codes

- 85100000 - Health services

## Release History

- 12 Jan 2024 at 16:35 - Tender - Tender Notice - https://www.find-tender.service.gov.uk/Notice/001167-2024

## Notice URLs

- https://health-family.force.com/s/Welcome
- https://www.ardengemcsu.nhs.uk/
- https://www.england.nhs.uk/

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-042ce3. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-042ce3.json.